Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

Delayed Data
As of Jan 17
 -0.92 / -1.51%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 19 analysts offering 12-month price forecasts for Ultragenyx Pharmaceutical Inc have a median target of 75.00, with a high estimate of 90.00 and a low estimate of 48.00. The median estimate represents a +25.08% increase from the last price of 59.96.

Analyst Recommendations

The current consensus among 19 polled investment analysts is to Buy stock in Ultragenyx Pharmaceutical Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 18

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 18.05%
Growthannually -74.78%


Growthquarterly 23.63%
Growthannually 94.58%
Key to the earnings and sales forecast charts.